SQI Diagnostics (TSXV:SQD.H) - Cours de l'action, nouvelles et analyse

SQD.H Aperçu des actions

A precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. Plus de détails

SQD.H analyse fondamentale
Score flocon de neige
Évaluation	2/6
Croissance future	0/6
Performances passées	0/6
Santé financière	0/6
Dividendes	0/6

Analyse des risques

N'a pas de capitalisation boursière significative ( CA$6M )

Capitaux propres négatifs

Les actions sont très illiquides

Les derniers rapports financiers datent de plus d'un an

+ 2 plus de risques

SQI Diagnostics Inc. Concurrents

Scryb

CNSX:SCYB

CA$4.8m

ASEP Medical Holdings

CNSX:ASEP

CA$3.8m

Frequency Exchange

TSXV:FREQ

CA$6.6m

Evome Medical Technologies

TSXV:EVMT

CA$11.2m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour SQI Diagnostics
Historique des cours de bourse
Prix actuel de l'action	CA$0.015
Plus haut sur 52 semaines	CA$0.02
Plus bas sur 52 semaines	CA$0.015
Bêta	-0.38
1Variation sur 1 mois	n/a
Variation sur 3 mois	n/a
Variation sur 1 an	n/a
3Variation sur 3 ans	-90.91%
Variation sur 5 ans	-88.00%
Évolution depuis l'introduction en bourse	-99.23%

Nouvelles et mises à jour récentes

Recent updates

If You Had Bought SQI Diagnostics (CVE:SQD) Stock A Year Ago, You Could Pocket A 246% Gain Today

Dec 22

Is SQI Diagnostics (CVE:SQD) Using Debt Sensibly?

Nov 17

Rendement pour les actionnaires

	SQD.H	CA Medical Equipment	CA Marché
7D	0%	-1.4%	2.2%
1Y	n/a	2.5%	23.4%

Rendement vs Industrie: Données insuffisantes pour déterminer la performance de SQD.H par rapport au secteur Canadian Medical Equipment.

Rendement vs marché: Données insuffisantes pour déterminer la performance de SQD.H par rapport au marché Canadian.

Volatilité des prix

Is SQD.H's price volatile compared to industry and market?
SQD.H volatility
SQD.H Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	13.3%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Cours de l'action stable: SQD.H n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: Données insuffisantes pour déterminer l'évolution de la volatilité de SQD.H au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
1999	n/a	Andrew Morris	www.sqidiagnostics.com

SQI Diagnostics Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de SQI Diagnostics se comparent-ils à sa capitalisation boursière ?
SQD.H statistiques fondamentales
Capitalisation boursière	CA$6.11m
Bénéfices(TTM)	-CA$19.14m
Recettes(TTM)	CA$3.05m

2.0x

Ratio P/S

-0.3x

Ratio P/E

Le site SQD.H est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
SQD.H compte de résultat (TTM)
Recettes	CA$3.05m
Coût des recettes	CA$3.19m
Marge brute	-CA$140.00k
Autres dépenses	CA$19.00m
Les revenus	-CA$19.14m

Derniers bénéfices déclarés

Mar 31, 2023

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	-0.047
Marge brute	-4.60%
Marge bénéficiaire nette	-628.51%
Ratio dettes/capitaux propres	-103.3%

Quelles ont été les performances à long terme de SQD.H?

Voir les performances historiques et les comparaisons

SQD.H Aperçu des actions

Analyse des risques

SQI Diagnostics Inc. Concurrents

CNSX:SCYB

CA$4.8m

CNSX:ASEP

CA$3.8m

TSXV:FREQ

CA$6.6m

TSXV:EVMT

CA$11.2m

Historique des prix et performances

Nouvelles et mises à jour récentes

SQI Diagnostics Inc. Ordinary Shares to Be Deleted from OTC Equity

SQI Diagnostics Inc. Listing to Transfer to NEX Effective Feb. 20

Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc

SQI Diagnostics Expects its Common Shares to Continue to be Halted from Trading on Exchange and Ultimately Suspended and Delisted Following Completion of the Filing

SQI Diagnostics Inc. Announces Executive Changes

SQI Diagnostics Inc., Annual General Meeting, Jun 30, 2023

Recent updates

SQI Diagnostics Inc. Ordinary Shares to Be Deleted from OTC Equity

SQI Diagnostics Inc. Listing to Transfer to NEX Effective Feb. 20

Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc

SQI Diagnostics Expects its Common Shares to Continue to be Halted from Trading on Exchange and Ultimately Suspended and Delisted Following Completion of the Filing

SQI Diagnostics Inc. Announces Executive Changes

SQI Diagnostics Inc., Annual General Meeting, Jun 30, 2023

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.007 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.009 loss in 1Q 2022)

SQI Diagnostics Inc., Annual General Meeting, Apr 05, 2023

Full year 2022 earnings released: CA$0.048 loss per share (vs CA$0.031 loss in FY 2021)

SQI Installs Two Rali-Dx Systems in Toronto Hospitals to Fight the Growing Respiratory Health Crisis in Emergency Departments

SQI Diagnostics Inc. announced that it expects to receive CAD 1 million in funding

SQI Diagnostics Inc. announced that it expects to receive CAD 2 million in funding from Federal Economic Development Agency for Southern Ontario

SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test

Third quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.002 loss in 3Q 2021)

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

SQI Diagnostics (CVE:SQD) Has Debt But No Earnings; Should You Worry?

New York State Approves SQI Diagnostics' Exact Covid-19 Antibody Assay

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

SQI Diagnostics Systems Inc. signed a definitive agreement to acquire all of the assets underlying Precision Biomonitoring Inc businesses from Precision Biomonitoring Inc. for CAD 6.825 million

SQI Diagnostics Inc. announced that it expects to receive CAD 6 million in funding

Third quarter 2021 earnings released: CA$0.002 loss per share (vs CA$0.005 loss in 3Q 2020)

Is SQI Diagnostics (CVE:SQD) Weighed On By Its Debt Load?

FDA Stops Emergency Use Authorization Review of SQI Diagnostics Inc. RALI-Dx IL-6 Severity Triage Test for Covid-19 Patients

CEO & Director Robert Chioini has left the company

Second quarter 2021 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 2Q 2020)

Health Check: How Prudently Does SQI Diagnostics (CVE:SQD) Use Debt?

Independent Director recently sold CA$56k worth of stock

Are Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?

First quarter 2021 earnings released: CA$0.012 loss per share (vs CA$0.009 loss in 1Q 2020)

Director exercised options to buy CA$705k worth of stock.

Director recently bought CA$660k worth of stock

New 90-day high: CA$0.40

SQI Diagnostics Inc., Annual General Meeting, Mar 31, 2021

Full year 2020 earnings released: CA$0.032 loss per share (vs CA$0.045 loss in FY 2019)

Is SQI Diagnostics Inc. (CVE:SQD) Popular Amongst Insiders?

SQI Diagnostics Announces Patient Enrollment Begins for its COVID-19 HOME Antibody Test Clinical Study

New 90-day high: CA$0.28

Independent Director exercised options to buy CA$1.7m worth of stock.

If You Had Bought SQI Diagnostics (CVE:SQD) Stock A Year Ago, You Could Pocket A 246% Gain Today

Is SQI Diagnostics (CVE:SQD) Using Debt Sensibly?

Sqi Diagnostics Inc. Updates Clinical Progress on Novel Covid-19 Tests Under Development for U.S. Fda Regulatory Submission

Third quarter earnings released

SQI Diagnostics Inc. Announces Executive Changes

New 90-day high - CA$0.21

Rendement pour les actionnaires

Volatilité des prix

À propos de l'entreprise

SQI Diagnostics Inc. Résumé des fondamentaux

2.0x

-0.3x

Bénéfices et recettes